Investors

Share price

{{priceData.date}} {{priceData.time}}

{{priceData.currentPrice}} {{priceData.currency}}
Go to stock watch {{priceData.change}} {{priceData.currency}}

Quick links

Financial results Stock information Press releases and company announcements R&D pipeline Upcoming events

Novo Nordisk Annual Report

Cover page of the Novo Nordisk Annual Report 2023

Annual Report 2023

Latest news

{{'2024-09-20T12:43:15Z' | dateFormatFilter}}

Novo Nordisk A/S: Monlunabant phase 2a trial in obesity successfully completed

Read more

{{'2024-09-19T19:10:20Z' | dateFormatFilter}}

Novo Nordisk A/S: Wegovy® recommended by the European regulatory authorities for label update to reflect reduced heart failure symptoms and improved physical function

Read more

{{'2024-08-07T05:31:04Z' | dateFormatFilter}}

Novo Nordisk's sales increased by 24% in Danish kroner and by 25% at constant exchange rates to DKK 133.4 billion in the first six months of 2024

Read more

News archive

Career Opportunities

Dear colleague

Please click here to go directly to our internal career site to view all our current job openings.

Here are our current job openings. If there is not a job you are looking for, you are welcome to create a job agent or a candidate profile.